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Abstract 
 
Lovastatin is an anti-cholesterol agent that was produced by Aspergillus terreus using solid state fermentation (SSF).  
During this fermentation process, sulochrin is also produced as an unwanted co-metabolite. However, our previous 
result showed that sulochrin had potential as antidiabetes because it is an inhibitor agent of α-glucosidase. In this paper, 
we reported our observation on lovastatin and sulochrin production pattern in relation with inhibitor α-glucosidase 
activity during eleven days fermentation of A. terreus koji (SSF) ethyl acetate extract. Koji obtained from solid state 
fermentation with rice as the substrate and incubated at room temperature, sample is taken daily for eleven day (D-1 to 
D-11). Lovastatin and sulochrin production was measured by Liquid Chromatography- Mass Spectrometer based on 
their molecular weight m/z 404.5 and 332.3 respectively. The inibitory activity is measured by inhibition model of koji 
extract against α-glucosidase (EC 3.2.1.20) from Saccharomyces cereviceae. The results show that lovastatin 
production was started on the day 2 (0.04 mg/g) and achieving the optimal production on day 7 (11.46 mg/g), while 
sulochrin production was started on day 4 (0.60 mg/g) and keep produced until the end of fermentation period at Day 11 
(3.11 mg/g). Koji extract was started to show inhibitory to α-glucosidase activity on Day 5 (IC50= 23.34 µg/mL) and 
keep showed activity until Day 11 (IC50=3.33 µg/mL). These results suggest that inhibitory activity of koji extract to α-
glucosidase activity have relation with sulochrin biosynthesis production. 
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1. Introduction 
 
Lovastatin (Mevinolin, Monocolin K, and MevacorTM) 
is potent drug for lowering blood cholesterol. Lovastatin 
act as competitively inhibition to the enzyme 3-hidroxy-
3-methylglutaryl coenzyme A reductase (HMG-CoA) 
with catalyzes the rate limiting step of cholesterol 
biosynthesis [1]. In the recent years, lovastatin has also 
been reported as a potential therapeutic agent for the 
treatment of various types of tumors because it 
suppresses tumor growth in vivo by inhibiting the 
synthesis of non-sterol isoprenoid compounds [2]. 
Lovastatin is produced as a secondary metabolite by the 
fungi Penicillium sp, Monascus ruber, and Aspergillus 
terreus [3].  
 
A. terreus is widely used lovastatin producer of the 
industrial importance [4], which is extensively excreted 
from  fungal cells into the medium in the form of β–
hydroxy acid-mevinolinicacid [5]. As a kind of 
secondary metabolite of fungi, lovastatin is an 
intracellular product and mostly accumulated in 
mycelia. Submerged fermentation processes for large-
scale lovastatin production have been developed using 
A. terreus [3,5,6]. In submerged fermentation, its yield 
is proportional to the amount of biomass, with the high 
cell density causing the increase of the fermentation 
broth viscosity and the difficulty in stirring and oxygen 
mass transfer; an alternative strategy to produce 
lovastatin is by solid state fermentation (SSF) [7]. 
 
In recent years, reseacher have show an increasing 
interest in solid state fermentation (SSF) as potential 
alternative of submerged fermentation, because it uses 
economical substrate, requires fewer processing and 
down-streaming stages, utilizes lesser power and 
generates lesser effluent [8]. Moreover, SSF has higher 
product yield and offers better product stability [2]. 
Except the low substrate cost and low energy 
consumption, the SSF process can offer a good 
environment for fungi to grow, therefore high mycelia 
density and high lovastatin production can be expected 
[2,7,9]. 
 
Nevertheless, such a microorganism of the rich 
secondary metabolism as A. terreus is also capable of 
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biosynthesis of other compound, such as sulochrin [10]. 
This compound is also a product of the polyketide 
synthase (PKS) pathway [11] and, as mevinolinic acid, 
is formed from malonyl-CoA and acetyl-CoA [4]. For 
the purpose of lovastatin production, sulochrin is 
considered as an unwanted co-metabolite due to the 
toxicities associated with the contaminants and/or due to 
difficulties in removing the contaminants during 
downstream processing [10]. 
 
In previous result, sulochrin isolated from the ethyl 
acetate extract of A. terreus by SSF using rice as 
substrate (koji), showed potential as α-glucosidase 
inhibitor and demonstrated depressed postprandial 
blood glucose level in mice [12]. Hence, A. terreus not 
only could produce anti cholesterol agent but also have 
possibility to produce anti diabetes. Therefore, the aim 
of this work was to do observation on lovastatin and 
sulochrin production pattern in relation with inhibitory 
activity to α-glucosidase during seven days fermentation 
of A. terreus koji (SSF) ethyl acetate extract. 
 
2. Methods 
 
Microorganism and growth condition. A wild-type 
strain A. terreus is a collection of Research Center for 
Chemisrty-Indonesian Institute of Sciences, was used in 
the present study. It was grown on maintained media 
slant containing: yeast extract (0.4%), malt (1%), 
dextrose (0.4%) and agar (2%), spores were collected 
after 7 days at 28 oC.  
 
Solid state fermentation. Solid substrate (1 kg rice) 
washed twice with water, drained, and autoclaved at 
121 oC for 15 min with addition of water (1:1). After 
cooling, media was inoculated with 50 ml (5%) of A. 
terreus culture grow on sporulation medium [13]. Media 
was thoroughly mixed, placed in sterile alummunium 
tray (10x10 cm) and incubated for 11 day at 28 °C. 
Every day, one tray was harvested to analyse lovastatin 
and sulochrin content, inhibition assay for α-glucosidase 
activity, reduced sugar were assayed by Somogyi 
Nelson (DNS) method, and organic nitrogen was 
determinant by Kjedahl method.  
 
Inhibition assay for α-glucosidase activity. The 
reaction mixture consisting 250 μL of 20 mM p-
nitorpehenyl α-D-glucopyranoside (Sigma Chemical 
Co), 495 μL of 100 mM phosphate buffer (pH 7.0) 
adding to flask contain 5 μL of sample dissolved in 
DMSO at various concentrations (3.125 to 25 μg/mL). 
The reaction mixture was pre-incubated for 5 min at 30 
°C, the reaction was start by adding 250 μL α-
Glucosidase (0.075 unit) (EC 3.2.1.20 from Wako Pure 
Chemical Industry) incubation was continued for 15 
min. The reaction stopped by adding 2 mL 0f 0.1 M 
Na2CO3. Enzymatic activity was quantified by 
measuring absorbance at 400 nm. IC50 value was 
defined as the concentration of α-glucosidase inhibitor 
that inhibited 50% of α-glucosidase activity. 
 
Extraction method. Fermented sample was extracted 
by 300 mL of ethyl acetate in 250 mL Erlenmeyer flask, 
shaked at 150 rpm for 1 day. The etyl acetate extract 
was concentrated in vacuo to give brown pasta. 
 
Analytical methods. The concentration of lovastatin 
and sulochrin was determined with Liquid 
Chromatography-Mass Spectrometer (Mariner 
Biospectrometry), system ESI (Electrospray Ionisation), 
positive ion mode, using Supelco C18 column (150 mm 
x 2 mm 1.d), acetonitril:water (95:5) was used as mobile 
phase, flow rate 1 mL/min. 
 
3. Results and Discussion 
 
The main composition of rice is used as substrate in SSF 
of A. terreus is starch. Its must be hydrolyzed into 
glucose to acetate, which is one of the compounds 
involved in biosynthesis of lovastatin. Although, A. 
terreus can produce amylase to hydrolize starch, in the 
beginning of the SSF process, there is not enough 
amylase secreted by cells. The amount of reduced sugar 
increased in the first three days due to the hydrolysis of 
starch by amylase which is secreted through the rapid 
growth of fungi [7]. After five days the reduced sugar 
was kept almost constant because of the dynamic 
balance between glucose formation and consumption  
(Fig. 1). Similiar patern also occur for protein content in 
the substrate after fermentation processed N content was 
increased as metabolism processed during fermentation 
of A. terreus.  
 
Our experimental results showed that sulochrin in ethyl 
acetate extract appeared at 1.7 min in a liquid 
chromatography, earlier than lovastatin which appeared 
 
 
 
Figure 1.  Time Courses of Reduced Sugar (♦) and Protein 
Content (•) during SSF Process 
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at 2.4 min (Fig. 2) with their molecular weight m/z 
333.13 [M+H]+, with m/z 405.17 [M+H]+ respectively 
(Fig. 3). In Fig. 4, the evolution curved for lovastatin 
and sulochrin production in SSF were presented. The 
formation of lovastatin  was start earlier on Day 2 (0.04 
mg/g), which explained that although lovastatin is a 
kind of secondary metabolite, its accumulation in 
mycelia seems growth related, which is different with 
the phenomena in submerged fermentation [7]. The 
maximum lovastatin yield was achieved on day 7 (11.46 
mg/g), after that, the lovastatin yield was decreasing 
slightly. While sulochrin production  was started on day 
4 (0.60 mg/g)  and keep produced until the end of 
fermentation period at Day 11 (3.11 mg/g). 
 
In our previous study on sulochrin isolation, we found 
that sulochrin showed α-glucosidase inhibitory activity 
not only at in vitro assay but also at in vivo experiment 
as measured in plasma glucose levels after sucrose 
administered to mice [12,13]. This result is similar with 
other published results which showed that several α-
glucosidase inhibitors have been isolated from the 
fermentation  broth and solid of certain microorganisms, 
 
 
 
Figure 2. The Chromatogram Sulochrin (Rt; 1.7) and 
Lovastatin (Rt;2.4) Standar 
 
 
 
Figure 3. The Mass Spectrum of Sulochrin and Lovastatin 
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Figure 4.  Time Course of Lovastatin (♦) and Sulochrin (•) 
Production during A. terreus SSF Process 
 
 
 
such as validamycin A from growth of Streptomyces 
hygroscopicus, Acarbose isolated from fermentation 
broth of Actinoplanes spp., reported traditionally 
fermented soybean product (Touchi) was found to 
possess strong α-glucosidase inhibitory activity [14,15]. 
Although, screening α-glucosidase inhibitory compound 
from solid state fermentation with rice as substrate have 
not reported yet. 
 
The results of α-glucosidase inhibitory activity assay 
during the process of A. terreus with rice (koji) 
presented in Tabel 1. Koji extract was started to show 
inhibitory to α-glucosidase activity on day 5 (IC50= 
23.34 µg/mL), which sulochrin produced was 1.46 
mg/g. Activity of α-glucosidase inhibitory increasing 
rapidly during the first 7 days of fermentation process, 
this phenomenon might be due to the increase of 
secondary metabolite production during fermentation. 
However, during the end of fermentation process, the 
activities are varied, this might be due to the present of 
metabolite(s) other than sulochrin that also responsible 
for inhibitory activity of α-glucosidase. 
 
Although, it is suggest that the metabolites might still 
have correlation with sulochriin biosynthetic pathway. 
During lovastatin fermentation process, this compound   
is present at polyketide pathway that originate from 
malonyl-CoA and acetyl-Co-A, which as same as 
sulochrin biosynthesis pathway [4]. Sulochrin may be 
further modified to form geodin (C17H12Cl2O7; m/z 
399.183) [11] this suggestion is supported with the LC-
MS result (m/z [M+CH3CN+H]+ = [M+42] = 441.95). 
Geodin is known to have ability to enhance (stimulate) 
glucose uptake by rat adipocytes and sulochrin is the 
precursor of geodin [16]. However, the present of other 
inhibitor compound(s) that has no relation with 
sulochrin production is still possible, since as mention 
earlier other α-glucosidase inhibitors by other microbes 
have been reported [14,15]. 
 
 
4. Conclusion 
 
The maximum yield of lovastatin was achieved on day 7 
(11.40 mg/g), while the maximum sulochrin was 
achieved on day 8 (5.26 mg/g) at SSF using rice as a 
substrate of A. terreus α-glucosidase inhibitor activity is 
assumed to relate to the biosynthesis sulochrin. 
Therefore, SSF of A. terreus is a potential system to be 
used for production of anti-cholesterol and/or 
antidiabetes compounds. 
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